Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: Association with -7/7q-

Cancer Genetics and Cytogenetics

Volumn 104, Issue 2, 1998, Pages 94-97

  Kwong, Y L ^a   Au, W Y ^a   Liang, R H S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CANCER RISK; CASE REPORT; CHROMOSOME 7Q; CHROMOSOME DELETION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LONG TERM CARE; MUTAGENICITY; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE DISEASE; ADULT; AGED; ARTHRITIS, RHEUMATOID; AZATHIOPRINE; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; MUTAGENS;

EID: 0032527868     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00456-1     Document Type: Article

References (21)

1. Kinlen L.J. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med. 78(suppl 1A):1985;44-49.
2. Kinlen L.J. Malignancy in autoimmune diseases. J Autoimmun. 5(suppl A):1992;363-371.
3. Matteson E.L., Hickey A.R., Maguire L., Tilson H.H., Urowitz M.B. Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee J Rheumatol. 18:1991;809-814.
4. Mok C.C., Kwong Y.L., Lau C.S. Secondary acute myeloid leukaemia with 7q- complicating azathioprine treatment for rheumatoid arthritis. Ann Rheumatol Dis. 54:1995;155-156.
5. Kwong Y.L., Chan L.C. Involvement of eosinophils in acute myeloid leukemia with monosomy 7 demonstrated by in situ hybridization. Br J Haematol. 88:1994;389-391.
6. Mitelman F., Brandt L., Nilsson P.G. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings and bone marrow chromosomes in acute non-lymphocytic leukaemia. Blood. 52:1987;1229-1237.
7. Golomb H.M., Alimena G., Rowley J.D., Vardiman J.W., Testa J.R., Sovik C. Correlation of occupation and karyotype in adults with acute non-lymphocytic leukemia. Blood. 60:1982;404-411.
8. Le Beau M.M., Albain K.S., Larson R.A., Vardiman J.W., Davis E.M., Blough R.R., Golomb H.M., Rowley J.D. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute non-lymphocytic leukemia. further evidence for characteristic abnormalities of chromosomes no. 5 and no. 7 J Clin Oncol. 4:1986;325-345.
9. Pedersen-Bjergaard J., Philip P. Cytogenetic characteristics of therapy-related acute non-lymphocytic leukaemia, preleukaemia and acute myeloproliferative syndrome. correlation with clinical data for 61 consecutive cases Br J Haematol. 66:1987;199-208.
10. Schmalzl F., Mufti G.J. Myelodysplastic Syndromes. 1991;Springer Verlag, New York.
11. Chabner BA, Myers CE (1989): Clinical pharmacology of cancer chemotherapy. In: Cancer: Principles and Practice of Oncology. VT DeVita Jr, S Hellman, SA Rosenberg, eds. Lippincott, Philadelphia, pp. 349-395.
12. Barrett W.L., First M.R., Aron B.S., Penn I. Clinical course of malignancies in renal transplant recipients. Cancer. 72:1993;2186-2189.
13. Melosky B., Karim M., Chui A., McBride M., Cameron E.C., Yeung C.K., Loandsberg D., Shackton C., Keown P.A. Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression. J Am Soc Nephrol. 2(suppl 12):1992;S290-S294.
14. Brunner F.P., Landais P., Selwook N.H. Maligancies after renal transplantation. the EDTA-ERA registry experience. European Dialysis and Transplantation Association - European Renal Association Nephrol Dial Transplant. 10(suppl 1):1995;74-80.
15. Arellano F., Krupp P. Malignancies in rheumatoid arthritis patients treated with cyclosporin A. Br J Rheumatol. 32(suppl 1):1993;72-75.
16. Baker G., Kahl C.E., Zee B.C., Stolzer B.L., Agarwal A.K., Medsger T.A. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Am J Med. 83:1987;1-9.
17. Vismans J.J., Briët E., Meijer K., den Ottolander G.J. Azathioprine and subacute myelomonocytic leukemia. Acta Med Scand. 207:1980;315-319.
18. Vasquez S., Kavanaugh A.F., Schneider N.R., Wacholtz M.C., Lipsky P.E. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents. J Rheumatol. 19:1992;1625-1627.
19. Krishnan K., Adams P., Silveira S., Sheldon S., Dabich L. Therapy-related acute myeloid leukaemia following immunosuppression with azathioprine for polymyositis. Clin Lab Haematol. 16:1994;285-289.
20. Dombret H., Marolleau J.P. De novo acute myeloid leukemia in patients with Crohn's disease. Nouv Rev Fr Hematol. 37:1995;193-196.
21. Renneboog B., Hansen V., Heimann P., De Mulder A., Janssen F., Ferster A. Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7. Br J Haematol. 92:1996;696-698.